首页> 外国专利> Cyclohexylamine derivatives as antagonists of selective n-methyl-d-aspartate subtypes

Cyclohexylamine derivatives as antagonists of selective n-methyl-d-aspartate subtypes

机译:环己胺衍生物作为选择性n-甲基-d-天冬氨酸亚型的拮抗剂

摘要

"CYCLHEXYLAMINE DERIVATIVES AS ANTAGONISTS OF SELECTIVE N-METHYL-D-ASPARTATE SUBTIPOSES". Derivatives of Formula 1 and pharmaceutically acceptable salts thereof are described, wherein R 1, g, R, V, B, E, Y, G, H, X 1, and d are as defined above in the description. . The compounds of Formulas I and VI are NMDA receptor channel complex antagonists useful for the treatment of cerebral vascular disorders such as, for example, stroke, cerebral ischemia, trauma, hypoglycemia, anxiety, migraine, seizures, Parkinson's disease, hearing loss induced by aminoglycoside antibiotics, psychosis, glaucoma, CMV retinitis, opioid tolerance or withdrawal, chronic pain, or urinary incontinence.
机译:“环己胺衍生物作为选择性的N-甲基-D-天冬氨酸取代基的拮抗剂”。描述了式1的衍生物及其药学上可接受的盐,其中R 1,g,R,V,B,E,Y,G,H,X 1和d如以上描述中所定义。 。式I和VI的化合物是NMDA受体通道复合物拮抗剂,可用于治疗脑血管疾病,例如中风,脑缺血,创伤,低血糖,焦虑症,偏头痛,癫痫发作,帕金森氏病,氨基糖苷诱导的听力损失抗生素,精神病,青光眼,CMV视网膜炎,阿片类药物耐受或戒断,慢性疼痛或尿失禁。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号